Gary Titus
2017
In 2017, Gary Titus earned a total compensation of $1.1M as Former Chief Financial Officer at UroGen Pharma Ltd., a 168% increase compared to previous year.
Compensation breakdown
Bonus | $25,000 |
---|---|
Non-Equity Incentive Plan | $125,125 |
Option Awards | $622,224 |
Salary | $304,167 |
Other | $1,161 |
Total | $1,077,677 |
Titus received $622.2K in option awards, accounting for 58% of the total pay in 2017.
Titus also received $25K in bonus, $125.1K in non-equity incentive plan, $304.2K in salary and $1.2K in other compensation.
Rankings
In 2017, Gary Titus' compensation ranked 8,629th out of 14,666 executives tracked by ExecPay. In other words, Titus earned more than 41.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,629 | 41st |
Manufacturing | 3,278 | 43rd |
Chemicals And Allied Products | 1,101 | 47th |
Drugs | 873 | 50th |
Pharmaceutical Preparations | 684 | 49th |
Titus' colleagues
We found three more compensation records of executives who worked with Gary Titus at UroGen Pharma Ltd. in 2017.